Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

Transparency, prior authorization, PBM reform and PBM offered genomics testing are some the trends Formulary Watched tracked ...

Across industries, competition between a few dominant players is not unusual, but in healthcare, its effects extend well beyond standard business rivalry. When control over prescription drug access ...

Pharmacy costs remain one of the toughest challenges in employer-sponsored health plans, and comprehensive federal reform is likely a long way off. As Congress debates pharmacy benefit manager reform, ...

Cigna Group (NYSE:CI) said it expects margin pressure within the pharmacy benefit services segment over the next two years. During its earnings call, the company added that in Evernorth, it expects ...

If there is one thing that leaders from both sides of the political aisle in Washington, DC can agree on, it’s that pharmacy benefit management (PBM) reform is needed – and needed now. In 2024, nine ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Arkansas House Bill 1150 aims to protect independent pharmacies but may limit patient access and conflict with federal laws. Similar PBM legislation is emerging in other states, with varying degrees ...

Cigna (NYSE:CI) said that its health services division, Evernorth, which includes the pharmacy benefit manager Express Scripts, will eliminate the controversial practice of drug rebates for all of its ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Cigna (NYSE:CI) plans to phase out drug rebates for its commercial ...